139 related articles for article (PubMed ID: 38213497)
1. Role of leukapheresis in the management of acute kidney injury associated with hyperleukocytosis of acute myeloid leukemia.
Shah CV; Badra S; Farhadfar N
Clin Kidney J; 2024 Jan; 17(1):sfad284. PubMed ID: 38213497
[No Abstract] [Full Text] [Related]
2. Minimally early morbidity in children with acute myeloid leukemia and hyperleukocytosis treated with prompt chemotherapy without leukapheresis.
Chen KH; Liu HC; Liang DC; Hou JY; Huang TH; Chang CY; Yeh TC
J Formos Med Assoc; 2014 Nov; 113(11):833-8. PubMed ID: 24534017
[TBL] [Abstract][Full Text] [Related]
3. The management of hyperleukocytosis in 2017: Do we still need leukapheresis?
Korkmaz S
Transfus Apher Sci; 2018 Feb; 57(1):4-7. PubMed ID: 29477941
[TBL] [Abstract][Full Text] [Related]
4. Comparison of early mortality between leukapheresis and non-leukapheresis in adult acute myeloid leukemia patients with hyperleukocytosis: a systematic review and meta-analysis.
Rinaldi I; Sutandyo N; Winston K
Hematology; 2022 Dec; 27(1):141-149. PubMed ID: 35068391
[TBL] [Abstract][Full Text] [Related]
5. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience.
Berber I; Kuku I; Erkurt MA; Kaya E; Bag HG; Nizam I; Koroglu M; Ozgul M; Bazna S
Transfus Apher Sci; 2015 Oct; 53(2):185-90. PubMed ID: 25843763
[TBL] [Abstract][Full Text] [Related]
6. Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience.
Haase R; Merkel N; Diwan O; Elsner K; Kramm CM
Klin Padiatr; 2009; 221(6):374-8. PubMed ID: 19890790
[TBL] [Abstract][Full Text] [Related]
7. Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis - a retrospective study from a tertiary center.
Nan X; Qin Q; Gentille C; Ensor J; Leveque C; Pingali SR; Phan AT; Rice L; Iyer S
Leuk Lymphoma; 2017 Sep; 58(9):1-11. PubMed ID: 28140714
[TBL] [Abstract][Full Text] [Related]
8. The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study.
Choi MH; Choe YH; Park Y; Nah H; Kim S; Jeong SH; Kim HO
Transfusion; 2018 Jan; 58(1):208-216. PubMed ID: 28960357
[TBL] [Abstract][Full Text] [Related]
9. Leukapheresis treatment in elderly acute leukemia patients with hyperleukocytosis: A single center experience.
Berber I; Erkurt MA; Kuku I; Kaya E; Gozukara Bag H; Nizam I; Koroglu M; Yigit A; Ozgul M
J Clin Apher; 2016 Feb; 31(1):53-8. PubMed ID: 26011305
[TBL] [Abstract][Full Text] [Related]
10. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis.
Bug G; Anargyrou K; Tonn T; Bialleck H; Seifried E; Hoelzer D; Ottmann OG
Transfusion; 2007 Oct; 47(10):1843-50. PubMed ID: 17880610
[TBL] [Abstract][Full Text] [Related]
11. The Role of Leukapheresis in the Current Management of Hyperleukocytosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia.
Nguyen R; Jeha S; Zhou Y; Cao X; Cheng C; Bhojwani D; Campbell P; Howard SC; Rubnitz J; Ribeiro RC; Sandlund JT; Gruber T; Inaba H; Pui CH; Metzger ML
Pediatr Blood Cancer; 2016 Sep; 63(9):1546-51. PubMed ID: 27187265
[TBL] [Abstract][Full Text] [Related]
12. Hyperleukocytosis in acute myeloid leukemia patients is associated with high 30-day mortality which is not improved with leukapheresis.
Wong GC
Ann Hematol; 2015 Dec; 94(12):2067-8. PubMed ID: 26255280
[No Abstract] [Full Text] [Related]
13. Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: a systematic review and meta-analysis.
Oberoi S; Lehrnbecher T; Phillips B; Hitzler J; Ethier MC; Beyene J; Sung L
Leuk Res; 2014 Apr; 38(4):460-8. PubMed ID: 24472688
[TBL] [Abstract][Full Text] [Related]
14. [Successful induction therapy for acute myeloid leukemia complicated with brain hemorrhage and hyperleukocytosis].
Miyazaki T; Abe N; Yamazaki E; Koyama S; Miyashita K; Takahashi H; Nakajima Y; Tachibana T; Kamijo A; Tomita N; Ishigastubo Y
Rinsho Ketsueki; 2016 Feb; 57(2):180-5. PubMed ID: 26935637
[TBL] [Abstract][Full Text] [Related]
15. Leukapheresis in patients newly diagnosed with acute myeloid leukemia.
Villgran V; Agha M; Raptis A; Hou JZ; Farah R; Lim SH; Redner RL; Im A; Sehgal A; Dorritie KA; Kiss JE; Normolle D; Boyiadzis M
Transfus Apher Sci; 2016 Oct; 55(2):216-220. PubMed ID: 27470709
[TBL] [Abstract][Full Text] [Related]
16. Hyperleukocytosis in Acute Myeloid Leukemia: Considerations for Inpatient Diagnosis and Management.
Wheatley TT; Foster Castiglione H; Phong K; Yoon M
Clin J Oncol Nurs; 2023 Nov; 27(6):589-593. PubMed ID: 38009885
[TBL] [Abstract][Full Text] [Related]
17. Leukapheresis in Pediatric Acute Leukemia with Hyperleukocytosis: A Single-Center Experience.
Jones SR; Rahrig A; Saraf AJ
Children (Basel); 2022 Apr; 9(4):. PubMed ID: 35455547
[TBL] [Abstract][Full Text] [Related]
18. Leukapheresis Does Not Improve Early Survival Outcome of Acute Myeloid Leukemia with Leukostasis Patients - A Dual-Center Retrospective Cohort Study.
Rinaldi I; Sari RM; Tedhy VU; Winston K
J Blood Med; 2021; 12():623-633. PubMed ID: 34290537
[TBL] [Abstract][Full Text] [Related]
19. Leukapheresis do not improve early death rates in acute myeloid leukemia patients with hyperleukocytosis.
Malkan UY; Ozcebe OI
Transfus Apher Sci; 2017 Dec; 56(6):880-882. PubMed ID: 29153308
[TBL] [Abstract][Full Text] [Related]
20. Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia-A systematic review and meta-analysis.
Bewersdorf JP; Giri S; Tallman MS; Zeidan AM; Stahl M
Transfusion; 2020 Oct; 60(10):2360-2369. PubMed ID: 32776542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
